Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × Ifosfamide × Clear all

Sponsor

Conditions

Sarcoma 22 Lymphoma 13 Hodgkin Disease 11 Osteosarcoma 10 Lymphoma, Large B-Cell, Diffuse 9 Testicular Neoplasms 8 Teratoma 6 Ovarian Neoplasms 6 Neoplasms 6 Lymphoma, Non-Hodgkin 6 Recurrence 5 Neuroectodermal Tumors, Primitive, Peripheral 5 Testicular Germ Cell Tumor 4 Central Nervous System Neoplasms 4 Burkitt Lymphoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Ovarian Germ Cell Cancer 3 Neurofibrosarcoma 3 Lymphoma, Mantle-Cell 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, B-Cell 3 Histiocytoma, Malignant Fibrous 3 Fibrosarcoma 3 Endodermal Sinus Tumor 3 Carcinoma, Embryonal 3 Vomiting 2 Seminoma 2 Sarcoma, Synovial 2 Sarcoma, Alveolar Soft Part 2 Rhabdomyosarcoma 2

Interventions

Gemcitabine 42 Cisplatin 29 pembrolizumab 25 Paclitaxel 12 Docetaxel 12 atezolizumab 11 Nivolumab 10 Mitomycin 10 avelumab 9 Carboplatin 9 Cystectomy 8 durvalumab 7 Sunitinib 7 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 apaziquone 5 Vinblastine 5 Platinum 5 Methotrexate 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4 vinflunine 3 tisotumab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡